Back to Authors

Jonge, Maja J. De

A5084909777 | I4210149908

Mayo Clinic

Erasmus MC Cancer Institute

Citations 1

53BP1 as a predictor of response in PARP inhibitor-treated homologous recombination-deficient ovarian cancer.

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 5538-5538

10.1200/jco.2018.36.15_suppl.5538